MENU
Wednesday, September 7th, 1:00PM EDT

Managing Direct Oral Anticoagulant Inhibitor to Heparin Conversion; Heparin Anti-Xa assay or aPTT?

Sponsored by: Diagnostica Stago, Inc.
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract
Managing Direct Oral Anticoagulant Inhibitor to Heparin Conversion; Heparin Anti-Xa assay or aPTT?
 

Ever since the introduction of the direct oral anticoagulants (DOACs), such as apixaban and rivaroxaban, laboratory staff and clinicians have been confronted with unique challenges in determining optimal practices when transitions to heparin infusions are needed for patients at high risk of thrombosis. Heparin infusions are commonly needed for patient on DOACs who are admitted to the acute care setting, yet little guidance has been provided on how to manage these transitions. Due to these challenges, clinicians and their laboratory partners have been developing optimal processes to manage these transitions. Recently, a comprehensive practice guideline was published on how to manage these transitions along with an assessment of its performance versus an alternative strategy. This will be discussed in detail, and examples will be provided in using that guideline to manage care.

 
Learning Objectives
  • Describe the unique challenges transitioning a patient from a direct oral anticoagulant to a heparin infusion
  • Compare and contrast heparin anti-Xa assay levels to aPTT to manage heparin infusions
  • Evaluate recent literature developments on how to manage DOAC to heparin transitions
  • When presented with a patient on a DOAC transitioning to heparin, appropriately interpret laboratory values to appropriately manage the transition
 
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.  CE credits are available for this webinar up to 2 years from the date of the live broadcast.

Show Resources
You May Also Like
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
Loading Comments...
Show Resources
Event Countdown
  • 0 Days
  • 0 Hours
  • 0 Minutes
  • 0 Seconds